antiviral metallodrugs (MetalloPharm)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantiviral metallodrugs (MetalloPharm)
Drug Alias NameHCV metallodrug therapy (MetalloPharm)HCV therapy (MetalloPharm)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitors
TargetsHepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsHepatitis CVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMetalloPharm LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMetalloPharm LLC
Active IndicationsN/A
Inactive IndicationsHepatitis CVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A